ES2532502T3 - Proceso para la preparación de tenofovir - Google Patents
Proceso para la preparación de tenofovir Download PDFInfo
- Publication number
- ES2532502T3 ES2532502T3 ES07827516.1T ES07827516T ES2532502T3 ES 2532502 T3 ES2532502 T3 ES 2532502T3 ES 07827516 T ES07827516 T ES 07827516T ES 2532502 T3 ES2532502 T3 ES 2532502T3
- Authority
- ES
- Spain
- Prior art keywords
- tenofovir
- preparation process
- tenofovir disoproxil
- disoproxil hemifumarate
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title 1
- 229960004556 tenofovir Drugs 0.000 title 1
- VCMJCVGFSROFHV-WZGZYPNHSA-N tenofovir disoproxil fumarate Chemical compound OC(=O)\C=C\C(O)=O.N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N VCMJCVGFSROFHV-WZGZYPNHSA-N 0.000 title 1
- JFVZFKDSXNQEJW-CQSZACIVSA-N tenofovir disoproxil Chemical compound N1=CN=C2N(C[C@@H](C)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C)C=NC2=C1N JFVZFKDSXNQEJW-CQSZACIVSA-N 0.000 abstract 1
- 229960001355 tenofovir disoproxil Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Tenofovir disoproxil hemifumarato.
Description
DESCRIPCIÓN
Claims (1)
- REIVINDICACIONES
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
INCH12182006 | 2006-07-12 | ||
IN1218CH2006 | 2006-07-12 | ||
IN1352CH2006 | 2006-07-31 | ||
INCH13522006 | 2006-07-31 | ||
INCH04842007 | 2007-03-09 | ||
IN484CH2007 | 2007-03-09 | ||
PCT/IN2007/000286 WO2008007392A2 (en) | 2006-07-12 | 2007-07-11 | Process for the preparation of tenofovir |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2532502T3 true ES2532502T3 (es) | 2015-03-27 |
Family
ID=38923686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07827516.1T Active ES2532502T3 (es) | 2006-07-12 | 2007-07-11 | Proceso para la preparación de tenofovir |
Country Status (4)
Country | Link |
---|---|
US (1) | US8049009B2 (es) |
EP (1) | EP2046792B1 (es) |
ES (1) | ES2532502T3 (es) |
WO (1) | WO2008007392A2 (es) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008007392A2 (en) * | 2006-07-12 | 2008-01-17 | Matrix Laboratories Limited | Process for the preparation of tenofovir |
US20090270352A1 (en) * | 2007-05-22 | 2009-10-29 | Ultimorphix Technologies B.V. | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal |
WO2009064174A1 (en) * | 2007-11-14 | 2009-05-22 | Ultimorphix Technologies B.V. | Polymorphic form of tenofovir disoproxil fumarate, method for its preparation and use |
CA2713105C (en) | 2008-01-25 | 2016-06-07 | Chimerix, Inc. | Methods of treating viral infections |
NZ588796A (en) * | 2008-04-25 | 2012-07-27 | Cipla Ltd | Crystalline form of tenofovir disoproxil and a process for its preparation |
WO2010026603A2 (en) * | 2008-09-05 | 2010-03-11 | Matrix Laboratories Limited | Novel amine salts of tenofovir, process for producing the same and use thereof in production of tenofovir dioproxil |
CA2744211A1 (en) * | 2008-11-21 | 2010-05-27 | Ultimorphix Technologies B.V. | Wet granulation of tenofovir, emtricitabine and efavirenz |
CN101906119B (zh) * | 2009-06-03 | 2012-12-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 制备替诺福韦的新方法 |
WO2011014704A2 (en) | 2009-07-30 | 2011-02-03 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
ES2629165T3 (es) | 2010-02-12 | 2017-08-07 | Chimerix, Inc. | Métodos de tratamiento de una infección vírica |
WO2011111074A2 (en) | 2010-03-11 | 2011-09-15 | Matrix Laboratories Ltd | An improved process for the preparation of tenofovir disoproxil fumarate |
EP2563367A4 (en) | 2010-04-26 | 2013-12-04 | Chimerix Inc | METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES |
CN101870713A (zh) * | 2010-05-28 | 2010-10-27 | 杭州和素化学技术有限公司 | 一种替诺福韦酯的产业化生产工艺 |
AU2011288091B2 (en) * | 2010-08-01 | 2016-06-09 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Crystals of Tenofovir disoproxil fumarate |
ZA201103820B (en) * | 2010-12-13 | 2012-01-25 | Laurus Labs Private Ltd | Process for the preparation of tenofovir |
CN102219805A (zh) * | 2011-03-10 | 2011-10-19 | 苏州腾龙生物医药技术有限公司 | 一种新型的泰诺福韦生产工艺 |
CN103732594A (zh) | 2011-08-16 | 2014-04-16 | 吉联亚科学公司 | 替诺福韦艾拉酚胺(tenofovir alafenamide)半反丁烯二酸盐 |
WO2013072745A1 (en) | 2011-11-16 | 2013-05-23 | Laurus Labs Private Limited | Process for the preparation of tenofovir |
CN103374038B (zh) * | 2012-04-11 | 2016-04-13 | 广州白云山医药集团股份有限公司白云山制药总厂 | 一种抗病毒药物的制备方法 |
CN107312039B (zh) | 2012-08-30 | 2019-06-25 | 江苏豪森药业集团有限公司 | 一种替诺福韦前药的制备方法 |
GB201215696D0 (en) * | 2012-09-03 | 2012-10-17 | Ithemba Pharmaceuticals Pty Ltd | A process for the preparation of (R)-9-[2-(Phosphonometh-Oxy)propyl]adenine (PMPA) |
CN103848869B (zh) * | 2012-12-04 | 2016-12-21 | 上海医药工业研究院 | 制备替诺福韦的方法 |
CN103848868B (zh) * | 2012-12-04 | 2017-04-12 | 蚌埠丰原涂山制药有限公司 | 制备替诺福韦的方法 |
CN104045667A (zh) * | 2013-03-14 | 2014-09-17 | 上海卫思化学科技有限公司 | 一种替诺福韦酯半富马酸盐的制备方法 |
WO2015040640A2 (en) * | 2013-09-20 | 2015-03-26 | Laurus Labs Private Limited | An improved process for the preparation of tenofovir alafenamide or pharmaceutically acceptable salts thereof |
EP2860185A1 (en) | 2013-10-09 | 2015-04-15 | Zentiva, k.s. | An improved process for the preparation of Tenofovir disoproxil and pharmaceutically acceptable salts thereof |
PT2860184T (pt) | 2013-10-09 | 2018-11-20 | Zentiva Ks | Sal de di-hidrogenofosfato de tenofovir disoproxil |
MX362752B (es) | 2013-11-15 | 2019-02-07 | Chimerix Inc | Formas mórficas de ésteres de hexadeciloxipropil-fosfonato. |
TWI660965B (zh) * | 2014-01-15 | 2019-06-01 | 美商基利科學股份有限公司 | 泰諾福韋之固體形式 |
CN104530129A (zh) * | 2014-03-26 | 2015-04-22 | 广东东阳光药业有限公司 | 制备(r)-9-(2-磷酸甲氧基丙基)腺嘌呤的方法 |
CN104974188B (zh) * | 2014-04-11 | 2019-01-08 | 浙江九洲药业股份有限公司 | 一种替诺福韦酯晶型及其制备方法 |
CN104230992A (zh) * | 2014-08-27 | 2014-12-24 | 太仓运通生物化工有限公司 | 一种高纯度富马酸泰诺福韦酯的制备方法 |
CN106687467A (zh) * | 2014-09-30 | 2017-05-17 | 韩美精密化学株式会社 | 高纯度(r)‑9‑[2‑(磷酰甲氧基)丙基]腺嘌呤的制备方法 |
CN105985381B (zh) * | 2014-12-30 | 2018-10-30 | 安徽贝克联合制药有限公司 | 一种替诺福韦的制备方法 |
RU2665037C2 (ru) * | 2016-12-12 | 2018-08-27 | Общество с ограниченной ответственностью "Вириом" | Изопропил N-[{ [(1R)-2-(6-амино-9H-пурин-9-ил)-1-метилэтокси]метил} (1,3-бензотиазол-6-ил-окси)фосфорил]-L-аланинат фумарат в качестве противовирусного препарата - пролекарства Тенофовира |
CN110372748B (zh) * | 2018-04-12 | 2023-04-07 | 湖南千金湘江药业股份有限公司 | 一种无定形半富马酸替诺福韦二吡呋酯及其制备方法 |
CN110615814B (zh) * | 2019-09-10 | 2021-07-06 | 株洲千金药业股份有限公司 | 一种半富马酸替诺福韦二吡呋酯的制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5733788A (en) | 1996-07-26 | 1998-03-31 | Gilead Sciences, Inc. | PMPA preparation |
US5922695A (en) | 1996-07-26 | 1999-07-13 | Gilead Sciences, Inc. | Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability |
SG106657A1 (en) | 1997-07-25 | 2004-10-29 | Gilead Sciences Inc | Nycleotide analog composition and sythesis method |
US5935946A (en) * | 1997-07-25 | 1999-08-10 | Gilead Sciences, Inc. | Nucleotide analog composition and synthesis method |
US6465649B1 (en) | 1999-08-18 | 2002-10-15 | Gilead Sciences, Inc. | Methods for the dealkylation of phosphonate esters |
PT1301519E (pt) | 2000-07-21 | 2015-06-11 | Gilead Sciences Inc | Profármacos de análogos de nucleótidos de fosfonato e métodos para selecionar e preparar os mesmos |
WO2008007392A2 (en) * | 2006-07-12 | 2008-01-17 | Matrix Laboratories Limited | Process for the preparation of tenofovir |
US20090270352A1 (en) * | 2007-05-22 | 2009-10-29 | Ultimorphix Technologies B.V. | Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal |
US20110009368A1 (en) * | 2007-12-12 | 2011-01-13 | Ultimorphix Technologies B.V. | Solid forms of tenofovir disoproxil |
-
2007
- 2007-07-11 WO PCT/IN2007/000286 patent/WO2008007392A2/en active Application Filing
- 2007-07-11 EP EP07827516.1A patent/EP2046792B1/en not_active Not-in-force
- 2007-07-11 ES ES07827516.1T patent/ES2532502T3/es active Active
-
2009
- 2009-01-12 US US12/352,182 patent/US8049009B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2008007392A3 (en) | 2008-07-17 |
EP2046792B1 (en) | 2015-02-25 |
EP2046792A2 (en) | 2009-04-15 |
US8049009B2 (en) | 2011-11-01 |
US20090286981A1 (en) | 2009-11-19 |
WO2008007392A2 (en) | 2008-01-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2532502T3 (es) | Proceso para la preparación de tenofovir | |
ES2370416T5 (es) | Método para preparar polímeros de bajo peso molecular | |
ES2528026T3 (es) | Sales de oxalato de ivabridina cristalino y polimorfos de los mismos | |
ES2644750T3 (es) | Gaviones | |
ES2448766T9 (es) | Profármacos de dolutegravir | |
ES2643718T3 (es) | Identificación de dianas de ARN usando helicasas | |
JP2008542211A5 (es) | ||
JP2008514563A5 (es) | ||
JP2009139957A5 (es) | ||
JP2008543830A5 (es) | ||
DE602006003782D1 (de) | Bilderzeugungsgerät | |
NL1032236A1 (nl) | Glasloos stereoscopisch display. | |
CR10157A (es) | Compuestos químicos | |
NL1030791A1 (nl) | Stereoscopisch projectiesysteem. | |
DE602006019185D1 (de) | Bilderzeugungsvorrichtung | |
DE602006001618D1 (de) | Vorrichtung zur optischen Tomographie | |
JP2009249684A5 (es) | ||
ES2403197T5 (es) | Instalación de lavado | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
JP2007520206A5 (es) | ||
JP2010530463A5 (es) | ||
DE602006017762D1 (de) | Bilderzeugungsgerät | |
JP2010243737A5 (es) | ||
NI200700175A (es) | Procesos para la preparación de alcoholes de aminoetoxibencilo | |
JP2010525147A5 (es) |